141 related articles for article (PubMed ID: 27559400)
1. Beta-hydroxyphosphonate ribonucleoside analogues derived from 4-substituted-1,2,3-triazoles as IMP/GMP mimics: synthesis and biological evaluation.
Nguyen Van T; Hospital A; Lionne C; Jordheim LP; Dumontet C; Périgaud C; Chaloin L; Peyrottes S
Beilstein J Org Chem; 2016; 12():1476-86. PubMed ID: 27559400
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of β-hydroxyphosphonate nucleoside analogues as cytosolic 5'-nucleotidase II potential inhibitors: synthesis, in vitro evaluation and molecular modeling studies.
Meurillon M; Marton Z; Hospital A; Jordheim LP; Béjaud J; Lionne C; Dumontet C; Périgaud C; Chaloin L; Peyrottes S
Eur J Med Chem; 2014 Apr; 77():18-37. PubMed ID: 24607586
[TBL] [Abstract][Full Text] [Related]
4. 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
Ghoteimi R; Braka A; Rodriguez C; Cros-Perrial E; Tai Nguyen V; Uttaro JP; Mathé C; Chaloin L; Ménétrier-Caux C; Jordheim LP; Peyrottes S
Bioorg Chem; 2021 Feb; 107():104577. PubMed ID: 33450542
[TBL] [Abstract][Full Text] [Related]
5. An alternative pathway to ribonucleoside β-hydroxyphosphonate analogues and related prodrugs.
Hospital A; Meurillon M; Peyrottes S; Périgaud C
Org Lett; 2013 Sep; 15(18):4778-81. PubMed ID: 24015803
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II).
Ipata PL; Tozzi MG
Purinergic Signal; 2006 Nov; 2(4):669-75. PubMed ID: 18404470
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.
Sala-Newby GB; Freeman NV; Skladanowski AC; Newby AC
J Biol Chem; 2000 Apr; 275(16):11666-71. PubMed ID: 10766785
[TBL] [Abstract][Full Text] [Related]
9. 7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.
Kozarski M; Kubacka D; Wojtczak BA; Kasprzyk R; Baranowski MR; Kowalska J
Bioorg Med Chem; 2018 Jan; 26(1):191-199. PubMed ID: 29195795
[TBL] [Abstract][Full Text] [Related]
10. Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.
Kubacka D; Kozarski M; Baranowski MR; Wojcik R; Panecka-Hofman J; Strzelecka D; Basquin J; Jemielity J; Kowalska J
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631380
[TBL] [Abstract][Full Text] [Related]
11. Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
Guillon R; Rahimova R; Preeti ; Egron D; Rouanet S; Dumontet C; Aghajari N; Jordheim LP; Chaloin L; Peyrottes S
Eur J Med Chem; 2019 Apr; 168():28-44. PubMed ID: 30798051
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of stable aminoacyl-tRNA analogues containing triazole as a bioisoster of esters.
Chemama M; Fonvielle M; Arthur M; Valéry JM; Etheve-Quelquejeu M
Chemistry; 2009; 15(8):1929-38. PubMed ID: 19035586
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of cytosolic 5'-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine.
Barsotti C; Pesi R; Giannecchini M; Ipata PL
J Biol Chem; 2005 Apr; 280(14):13465-9. PubMed ID: 15699053
[TBL] [Abstract][Full Text] [Related]
14. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism.
Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG
Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773
[TBL] [Abstract][Full Text] [Related]
15. The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.
Cividini F; Pesi R; Chaloin L; Allegrini S; Camici M; Cros-Perrial E; Dumontet C; Jordheim LP; Tozzi MG
Biochem Pharmacol; 2015 Mar; 94(2):63-8. PubMed ID: 25656700
[TBL] [Abstract][Full Text] [Related]
16. Initial studies to define the physiologic role of cN-II.
Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970
[TBL] [Abstract][Full Text] [Related]
17. Efficient atropodiastereoselective access to 5,5'-bis-1,2,3-triazoles: studies on 1-glucosylated 5-halogeno 1,2,3-triazoles and their 5-substituted derivatives as glycogen phosphorylase inhibitors.
Goyard D; Chajistamatiou AS; Sotiropoulou AI; Chrysina ED; Praly JP; Vidal S
Chemistry; 2014 Apr; 20(18):5423-32. PubMed ID: 24677199
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells.
Careddu MG; Allegrini S; Pesi R; Camici M; Garcia-Gil M; Tozzi MG
Biochim Biophys Acta; 2008 Aug; 1783(8):1529-35. PubMed ID: 18445485
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Antifungal Activity of Novel 2-Ar-1,2,3-Triazole Derivatives.
Yin X; Wang L; Liu S; Li Y
J Agric Food Chem; 2023 Nov; 71(43):15963-15970. PubMed ID: 37787985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
